Johnson & Johnson recently announced a series of initiatives in high tuberculosis (TB) burden countries to empower a generation of youth to end TB and increase disease detection.
The...
Digital healthcare solutions company, Vivalink, will provide its Biometric Data Platform to help detect neutropenic fever events in oncology patients.
Vivalink is at the forefront of...
Moderna will expand its mRNA vaccine pipeline through two new development programs, including a combination respiratory vaccine candidate and a program against four endemic human coronaviruses...
Thermo Fisher Scientific will invest $97 million to expand its clinical research operations in Virginia to support the increasing demand for drug development.
Over the next three years,...
AstraZeneca recently launched a global research and development Postdoctoral Challenge to help advance drug discovery for some of the world’s most complex diseases.
The challenge invites...
Moderna recently dosed the first participant in an HIV trimer mRNA vaccine (mRNA-1574) clinical trial.
The open-label Phase 1 trial will evaluate the safety and immunogenicity of...
Civica recently announced plans to manufacture and distribute insulin to diabetes patients at significantly lower prices than insulins currently on the market.
Civica, CivicaScript, and the...
Novo Nordisk recently expanded its research collaboration in oral drug delivery technologies with the Massachusetts Institutes of Technology (MIT) and Brigham and Women’s Hospital...
Moderna recently announced its global public health strategy through four initiatives to advance mRNA vaccines for infectious diseases.
In the first strategy, Moderna will expand its global public...
The American Medical Association (AMA) recently strongly supported the Biden Administration's proposal for Medicare Advantage (MA) and prescription drug benefit policies in an official letter.
In...
FDA recently accepted for review the Prior Approval Supplement (PAS) to the Biologics License Application (BLA) for Pfizer’s interchangeable biosimilar to Humira, Abrilada.
Abrilada is a...
Half of all Medicare Part D covered drugs and nearly half of all Medicare Part B covered drugs (48%) had price increases greater than inflation between July 2019 and July 2020, according to...
Moderna and Thermo Fisher Scientific recently announced a 15-year collaboration agreement for dedicated large-scale manufacturing of Moderna’s COVID-19 vaccine and other mRNA vaccines in the...
Moderna recently expanded its mRNA pipeline with three new development programs, including an HSV mRNA vaccine, a varicella-zoster virus (VZV) vaccine, and a checkpoint cancer vaccine.
First, Moderna...
GSK recently announced that the consumer healthcare company from its proposed transaction with Pfizer will be named Haleon.
Haleon will be a new world leader in consumer healthcare, offering to bring...
Gilead recently announced one-year results from an ongoing Phase 2/3 CAPELLA trial evaluating its HIV-1 capsid inhibitor, lenacapavir, in individuals with multi-drug resistant HIV.
The trial...
Moderna and ROVI recently entered into a long-term collaboration to increase capacities for the compounding, aseptic filling, inspection, and manufacturing of mRNA vaccines and medicines over the next...
Merck recently announced that Keytruda, combined with chemotherapy and followed by Keytruda as monotherapy, prolonged event-free survival compared to chemotherapy followed by placebo in patients with...
FDA recently issued emergency use authorization for Eli Lilly and Company’s monoclonal antibody, bebtelovimab, which retains activity against the omicron variant.
The agency authorized the...
Bristol Myers Squibb recently granted $7.965 million to 24 US non-profit organizations to improve access to care for medically underserved patients across oncology, cardiology, immunology, and...
